Can an IL13 -1112 C/T (rs1800925) polymorphism predict responsiveness to neoadjuvant chemoradiotherapy and survival of Chinese Han patients with locally advanced rectal cancer?-Reference-Cited by-同舟云学术

Can an IL13 -1112 C/T (rs1800925) polymorphism predict responsiveness to neoadjuvant chemoradiotherapy and survival of Chinese Han patients with locally advanced rectal cancer?

Published:2016-05-04 Issue:23 Volume:7 Page:34149-34157
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Xiao Lin¹²³,Yu Xin¹²,Zhang Rong²⁴,Chang Hui¹²,Xi Shaoyan²⁵,Xiao Weiwei¹²,Zeng Zhifan¹²,Zhang Huizhong²⁵,Xu Ruihua²⁶,Gao Yuanhong¹²

Affiliation:

1. Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China

2. State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China

3. Department of Oncology, Section II, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-sen University, Jiangmen, China

4. Department of Endoscopy and Laser, Sun Yat-sen University Cancer Center, Guangzhou, China

5. Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China

6. Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting pathological response to chemoradiotherapy for rectal cancer: a systematic review;Expert Review of Anticancer Therapy;2021-01-14

2. Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer;International Journal of Molecular Sciences;2021-01-13

3. Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy;Frontiers in Pharmacology;2020-06-17